Skip to main content
. Author manuscript; available in PMC: 2018 Jan 3.
Published in final edited form as: J Am Coll Cardiol. 2017 Jan 3;69(1):13–24. doi: 10.1016/j.jacc.2016.10.048

Table 1.

Patient Characteristics by Outcome Analysis, Stratified by Presence of Alcohol Abuse.

Atrial
Fibrillation
n = 14 378 483
Myocardial
Infarction
n = 14 286 472
Congestive Heart
Failure
n = 14 043 590

No Alcohol
Abuse
n =
14 118 785
Alcohol
Abuse
n =
259 688
No Alcohol
Abuse
n =
14 028 715
Alcohol
Abuse
n =
257 757
No Alcohol
Abuse
n =
13 794 083
Alcohol
Abuse
n =
249 507
No. Medical Encounters, (per patient) 44 673 579
(3.2)
2 342 998
(9.0)
45 715 014
(3.3)
2 383 827
(9.2)
44 321 427
(3.2)
2 298 681
(9.2)

Age - yr. ± SD 49.1 ± 18.5 49.4 ± 14.2 49.0 ± 18.5 49.3 ± 14.2 48.6 ± 18.3 49.0 ± 14.1

Male sex 5 871 304
(42.5)
175 634
(69.0)
5 814 268
(42.3)
174 054
(68.9)
5 701 438
(42.2)
167 655
(68.6)

Race
 White 7 643 090
(54.1)
149 206
(57.5)
7 827 602
(54.5)
153 828
(57.9)
7 665 362
(54.4)
148 295
(57.9)

 Black 1 029 331
(7.3)
20 908
(8.1)
1 035 538
(7.2)
21 134
(8.0)
1 008 516
(7.2)
19 926
(7.8)

 Hispanic 3 534 696
(25.0)
65 518
(25.2)
3 554 723
(24.8)
66 363
(25.0)
3 513 290
(24.9)
64 192
(25.1)

 Asian/Pacific Islander 1 192 147
(8.4)
5 884
(2.3)
1 207 360
(8.4)
6 012
(2.3)
1 188 485
(8.4)
5 726
(2.2)

 Native American 34 151
(0.2)
2 037
(0.8)
34 446
(0.2)
2 056
(0.8)
33 896
(0.2)
1 995
(0.8)

 Other 685,337
(4.9)
16,132
(6.2)
692,220
(4.8)
16,350
(6.2)
681,702
(4.8)
15,839
(6.2)
Income Quartile
 1 Lowest 3 360 654
(23.8)
75 038
(28.9)
3 339 355
(23.8)
74 505
(28.9)
3 273 977
(23.7)
71 887
(28.2)

 2 3 520 100
(25.0)
68 732
(26.5)
3 497 753
(24.9)
68 249
(26.5)
3 436 910
(24.9)
66 037
(26.5)

 3 3 620 695
(25.6)
63 734
(24.5)
3 596 512
(25.6)
63 217
(24.5)
3 537 080
(25.6)
61 222
(24.5)

 4 Highest 3 617 336
(25.6)
52 184
(20.1)
3 595 095
(25.6)
51 786
(20.1)
3 546 116
(25.7)
50 361
(20.2)

HTN 2 463 603
(17.5)
61 864
(23.8)
2 403 689
(17.1)
60 614
(23.5)
2 244 850
(16.3)
55 683
(22.3)

DM 1 189 756
(8.4)
32 126
(12.4)
1 157 306
(8.3)
31 542
(12.2)
1 063 343
(7.7)
28 807
(11.6)

CAD 604 139
(4.3)
11 715
(4.5)
538 602
(3.8)
10 507
(4.1)
445 679
(3.2)
8 161
(3.3)

CKD 178 883
(1.3)
4 083
(1.6)
170 020
(1.2)
3 941
(1.5)
134 695
(1.0)
3 074
(1.2)

VHD 134 595
(1.0)
2 691
(1.0)
126 091
(0.9)
2 514
(1.0)
95 148
(0.7)
1 609
(0.6)

DL 1 002 639
(7.1)
17 902
(6.9)
955 148
(6.8)
17 099
(6.6)
886 336
(6.4)
15 359
(6.2)

Smoking 595 787
(4.2)
48 833
(18.8)
579 178
(4.1)
48 013
(18.6)
560 075
(4.1)
45 442
(18.2)

Obese 431 950
(3.1)
8 431
(3.3)
421 487
(3.0)
8 231
(3.2)
393 784
(2.9)
7 279
(2.9)

OSA 104 979
(0.7)
2 287
(0.9)
102 755
(0.7)
2 236
(0.9)
91 745
(0.7)
1 777
(0.7)

Baseline characteristics are for patients included in the incident myocardial infarction, congestive heart failure, and atrial fibrillation analyses; individuals with prevalent MI, CHF, and AF have been excluded from each analysis, respectively. CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; DL, dyslipidemia; DM, diabetes; OSA, obstructive sleep apnea; SD, standard deviation; Smoking, current cigarette smoking; VHD, valvular heart disease.

Dichotomous variables (using Chi2 Test) and continuous variables (using Student’s t-test) were compared within each analysis – P<0.0001 for all comparisons, except in CHF analysis: CAD, P=0.264, VHD, P=0.007; Obese, P=0.063; OSA, P=0.004

Values are numbers (percentages) unless otherwise indicated.